Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy

前驱期突触核蛋白病的神经可塑性以及运动和认知缺陷的出现

基本信息

  • 批准号:
    10419719
  • 负责人:
  • 金额:
    $ 233.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-15 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Abstract Parkinson’s disease, dementia with Lewy bodies, and related synucleinopathies have a long prodromal stage, lasting years to decades, during which neurodegeneration progresses insidiously across the nervous system. Compensatory neuroplastic changes in structural and functional connectivity are thought to occur during the prodromal stage that mask the expression of motor and non-motor signs, which could markedly delay diagnosis during a critical therapeutic window. Alternatively, neuroplastic changes in structure and function may contribute to the emergence and/or exacerbation of motor and non-motor signs. Currently, little is known about the temporal evolution of structural and functional adaptations, the state of cortical neuroplasticity, and how these factors contribute to the masking and/or emergence of motor and cognitive signs during prodromal disease. This project will study the progression of disease in people with isolated rapid eye movement (REM) behavior sleep disorder (iRBD), a sleep disturbance characterized by elevated muscle activity during REM sleep, in conjunction with dream enactment. IRBD is recognized as a prodromal stage of synucleinopathy since more than 70% of people with this disorder eventually develop Parkinson’s disease, dementia with Lewy bodies, or multiple system atrophy. The goal of this project is to characterize the temporal evolution of neuroplastic changes in the structure and function of the brain in people with iRBD and to identify factors contributing to the masking and/or emergence of motor and cognitive signs. Aim 1 will use ultra-high field MRI at 7T to obtain measures of structural (diffusion tensor) and functional (rest-state) connectivity of prefrontal and sensorimotor pathways, their progression over two years, and their relationships to measures of motor and cognitive function. Aim 2 will use paired associative stimulation (peripheral nerve stimulation paired with transcranial magnetic stimulation) to examine the state and progression of long-term potentiation (LTP)-like plasticity in motor cortical pathways and its relationship to measures of motor function. Similarly, Aim 3 will use paired associative stimulation to examine the state and progression of LTP-like plasticity in prefrontal cortex and its relationship to measures of cognitive function and gait. Aim 4 will look at the relationships between the level of REM sleep muscle activity, the state of structural and functional connectivity, and cortical neuroplasticity and the progression of motor and cognitive signs. This project will provide unique insight into the temporal evolution of neuroplastic changes in the brain during prodromal disease in people at high risk of developing parkinsonism, dementia with Lewy bodies, or related synucleinopathies.
摘要 帕金森病、路易体痴呆和相关的突触核蛋白病具有长的前驱期, 持续数年至数十年,在此期间,神经变性在神经系统中不知不觉地进行。 结构和功能连接的补偿性神经可塑性变化被认为发生在脑缺血期间。 前驱期掩盖了运动和非运动体征的表达,这可能会显着延迟 在关键的治疗窗口期间进行诊断。或者,神经可塑性的结构和功能变化 可能导致运动和非运动体征的出现和/或恶化。目前,人们所知甚少 关于结构和功能适应的时间演变,皮质神经可塑性的状态,以及 这些因素如何有助于前驱期运动和认知体征的掩蔽和/或出现 疾病该项目将研究孤立性快速眼动(REM)患者的疾病进展 行为睡眠障碍(iRBD),一种以REM期间肌肉活动升高为特征的睡眠障碍 睡眠,与梦的实施相结合。IRBD被认为是突触核蛋白病的前驱期 因为超过70%的患有这种疾病的人最终会发展为帕金森病,路易痴呆, 身体或多系统萎缩。这个项目的目标是描述 iRBD患者大脑结构和功能的神经可塑性变化,并确定影响因素 有助于运动和认知体征的掩蔽和/或出现。Aim 1将使用超高场MRI 在7 T获得的结构(扩散张量)和功能(休息状态)的连接性的措施,前额叶和 感觉运动通路,它们在两年中的进展,以及它们与运动和 认知功能Aim 2将使用配对的联合刺激(外周神经刺激与 经颅磁刺激)检查长时程增强(LTP)样的状态和进展 运动皮层通路的可塑性及其与运动功能测量的关系。同样,Aim 3将使用 配对联想刺激检测前额叶皮层LTP样可塑性的状态和进展 及其与认知功能和步态测量的关系。目标4将研究 快速眼动睡眠肌肉活动水平,结构和功能连接的状态,以及皮质 神经可塑性以及运动和认知体征的进展。该项目将提供独特的见解, 高风险人群前驱疾病期间大脑神经可塑性变化的时间演变 发生帕金森综合征、路易体痴呆或相关的突触核蛋白病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

COLUM D MACKINNON其他文献

COLUM D MACKINNON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('COLUM D MACKINNON', 18)}}的其他基金

Mechanisms and effects of pallidal deep brain stimulation on levodopa resistant motor signs in Parkinson's disease
苍白球深部脑刺激对帕金森病左旋多巴抵抗运动体征的机制和影响
  • 批准号:
    10282963
  • 财政年份:
    2021
  • 资助金额:
    $ 233.62万
  • 项目类别:
Mechanisms and effects of pallidal deep brain stimulation on levodopa resistant motor signs in Parkinson's disease
苍白球深部脑刺激对帕金森病左旋多巴抵抗运动体征的机制和影响
  • 批准号:
    10703246
  • 财政年份:
    2021
  • 资助金额:
    $ 233.62万
  • 项目类别:
Mechanisms and effects of pallidal deep brain stimulation on levodopa resistant motor signs in Parkinson's disease
苍白球深部脑刺激对帕金森病左旋多巴抵抗运动体征的机制和影响
  • 批准号:
    10489834
  • 财政年份:
    2021
  • 资助金额:
    $ 233.62万
  • 项目类别:
Predictors of progression to freezing of gait in Parkinson's disease
帕金森病进展为冻结步态的预测因子
  • 批准号:
    9132362
  • 财政年份:
    2015
  • 资助金额:
    $ 233.62万
  • 项目类别:
Mechanisms of Movement Facilitation and Release by Cueing in Parkinson's disease
帕金森病中提示的运动促进和释放机制
  • 批准号:
    8542905
  • 财政年份:
    2011
  • 资助金额:
    $ 233.62万
  • 项目类别:
Mechanisms of Movement Facilitation and Release by Cueing in Parkinson's disease
帕金森病中提示的运动促进和释放机制
  • 批准号:
    8188218
  • 财政年份:
    2011
  • 资助金额:
    $ 233.62万
  • 项目类别:
Mechanisms of Movement Facilitation and Release by Cueing in Parkinson's disease
帕金森病中提示的运动促进和释放机制
  • 批准号:
    8325009
  • 财政年份:
    2011
  • 资助金额:
    $ 233.62万
  • 项目类别:
Control of Repetitive Movement in Parkinson's Disease
控制帕金森病的重复运动
  • 批准号:
    7413271
  • 财政年份:
    2006
  • 资助金额:
    $ 233.62万
  • 项目类别:
Control of Repetitive Movement in Parkinson's Disease
控制帕金森病的重复运动
  • 批准号:
    7591603
  • 财政年份:
    2006
  • 资助金额:
    $ 233.62万
  • 项目类别:
Control of Repetitive Movement in Parkinson's Disease
控制帕金森病的重复运动
  • 批准号:
    7236186
  • 财政年份:
    2006
  • 资助金额:
    $ 233.62万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 233.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 233.62万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 233.62万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 233.62万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 233.62万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 233.62万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 233.62万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 233.62万
  • 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 233.62万
  • 项目类别:
    Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 233.62万
  • 项目类别:
    Idea to Innovation
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了